©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Infect Dis. May 25, 2015; 5(2): 30-36
Published online May 25, 2015. doi: 10.5495/wjcid.v5.i2.30
Published online May 25, 2015. doi: 10.5495/wjcid.v5.i2.30
Origin of de novo daptomycin non susceptible enterococci
Theodoros Kelesidis, Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
Author contributions: Kelesidis T wrote the paper.
Conflict-of-interest: None.
Correspondence to: Theodoros Kelesidis, MD, PhD, Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, CHS 37-121, Los Angeles, CA 90095, United States. tkelesidis@mednet.ucla.edu
Telephone: +1-310-8257225 Fax: +1-310-2080140
Received: January 27, 2015
Peer-review started: January 28, 2015
First decision: March 20, 2015
Revised: April 1, 2015
Accepted: April 16, 2015
Article in press: April 20, 2015
Published online: May 25, 2015
Processing time: 112 Days and 15.2 Hours
Peer-review started: January 28, 2015
First decision: March 20, 2015
Revised: April 1, 2015
Accepted: April 16, 2015
Article in press: April 20, 2015
Published online: May 25, 2015
Processing time: 112 Days and 15.2 Hours
Core Tip
Core tip: Daptomycin non-susceptible enterococci (DNSE) is an emerging clinical problem and may be isolated from patients with or without (de novo DNSE) prior exposure to daptomycin. Recent epidemiological data suggest the presence of a community reservoir for DNSE which may be associated with environmental, foodborne and agricultural exposures and may be larger than previously thought. Herein, the limited available scientific evidence regarding the possible origin of de novo DNSE is discussed. Further studies to determine the mechanisms of de novo daptomycin nonsusceptibility among enterococci are needed.